Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bergfeldt

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
The American Journal of Medicine|August 1, 1983
HLA B27-associated rheumatic diseases with severe cardiac bradyarrhythmias. Clinical features and prevalence in 223 men with permanent pacemakersL Bergfeldt
Annals of Internal Medicine|October 27, 1997
HLA-B27-associated cardiac diseaseL Bergfeldt
Acta Medica Scandinavica|January 1, 1988
Atrial arrhythmias--the dominating cardiac problem in three patients with HLA B27 associated rheumatic disordersL Bergfeldt, M Rosenqvist
Cardiovascular Drugs and Therapy|August 1, 1995
"Normal" response of the QT interval and QT dispersion following intravenous injection of the sodium channel blocker disopyramide: methodological aspectsK Nowinski, L Bergfeldt
The Journal of Rheumatology|October 1, 1986
Pacemaker treated women with heart block have no increase in the frequency of HLA-B27 and associated rheumatic disorders in contrast to men--a sex linked difference in disease susceptibilityL Bergfeldt, E Möller
Journal of Internal Medicine|July 25, 2013
Atrial fibrillation prevalence revisitedL Friberg, L Bergfeldt
Tissue Antigens|May 1, 1983
Complete heart block--another HLA B27 associated disease manifestationL Bergfeldt, E Möller
American Heart Journal|September 1, 1995
Use of signal-averaged electrocardiography for predicting inducible sustained monomorphic ventricular tachycardia in patients with bundle branch block with and without a history of syncopeA Englund, M Rosenqvist, L Bergfeldt
British Heart Journal|February 1, 1984
Complete heart block in HLA B27 associated disease. Electrophysiological and clinical characteristicsL Bergfeldt, H Vallin, O Edhag
Cardiovascular Drugs and Therapy|October 1, 1995
Electrophysiological evaluation of the sodium-channel blocker carbamazepine in healthy human subjectsG Kennebäck, L Bergfeldt, T Tomson
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
The American Journal of Medicine|August 1, 1983
HLA B27-associated rheumatic diseases with severe cardiac bradyarrhythmias. Clinical features and prevalence in 223 men with permanent pacemakersL Bergfeldt
Annals of Internal Medicine|October 27, 1997
HLA-B27-associated cardiac diseaseL Bergfeldt
Acta Medica Scandinavica|January 1, 1988
Atrial arrhythmias--the dominating cardiac problem in three patients with HLA B27 associated rheumatic disordersL Bergfeldt, M Rosenqvist
Cardiovascular Drugs and Therapy|August 1, 1995
"Normal" response of the QT interval and QT dispersion following intravenous injection of the sodium channel blocker disopyramide: methodological aspectsK Nowinski, L Bergfeldt
The Journal of Rheumatology|October 1, 1986
Pacemaker treated women with heart block have no increase in the frequency of HLA-B27 and associated rheumatic disorders in contrast to men--a sex linked difference in disease susceptibilityL Bergfeldt, E Möller
Journal of Internal Medicine|July 25, 2013
Atrial fibrillation prevalence revisitedL Friberg, L Bergfeldt
Tissue Antigens|May 1, 1983
Complete heart block--another HLA B27 associated disease manifestationL Bergfeldt, E Möller
American Heart Journal|September 1, 1995
Use of signal-averaged electrocardiography for predicting inducible sustained monomorphic ventricular tachycardia in patients with bundle branch block with and without a history of syncopeA Englund, M Rosenqvist, L Bergfeldt
British Heart Journal|February 1, 1984
Complete heart block in HLA B27 associated disease. Electrophysiological and clinical characteristicsL Bergfeldt, H Vallin, O Edhag
Cardiovascular Drugs and Therapy|October 1, 1995
Electrophysiological evaluation of the sodium-channel blocker carbamazepine in healthy human subjectsG Kennebäck, L Bergfeldt, T Tomson
Pageof 6